DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
16.50
+0.25 (1.54%)
May 29, 2026, 3:00 PM CST
Market Cap18.79B -11.2%
Revenue (ttm)27.52B +3.1%
Net Income1.29B +31.8%
EPS1.13 +30.8%
Shares Out 1.14B
PE Ratio14.63
Forward PE13.63
Dividend0.98 (5.94%)
Ex-Dividend Daten/a
Volume4,862,903
Open16.25
Previous Close16.25
Day's Range16.23 - 16.68
52-Week Range15.34 - 21.78
Beta0.62
AnalystsBuy
Price Target24.49 (+48.42%)
Earnings DateApr 24, 2026

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Sector Healthcare
Founded 1999
Employees 41,141
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2025, SHA:603233's revenue was 27.50 billion, an increase of 3.80% compared to the previous year's 26.50 billion. Earnings were 1.24 billion, an increase of 35.04%.

Financial Statements